Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cocoon Bioscience has developed an automated platform leveraging insects in their chrysalis stage to produce complex recombinant proteins—primarily growth factors and specialty enzymes—at lower cost and higher scalability than traditional fermentation systems. Their technology is validated by the EMA for vaccine production. The company targets bottlenecks in supply chains for advanced therapies (mRNA vaccines/therapies), gene sequencing tools, cultivated meat industry inputs, etc.[1][2][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cocoon Bioscience.